Government of Greece Report issue

Government Phase 2 Phase 3

Organization Overview

First Clinical Trial
2013
NCT02409537
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

424 General Military Hospital | Aeromedical Center, Thessaloniki | Greek Secretariat for Research and Technology